Steward Partners Investment Advisory, LLC Neurocrine Biosciences Inc Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 100 shares of NBIX stock, worth $11,985. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 559
82.11%
Holding current value
$11,985
Previous $77,000
83.12%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NBIX
# of Institutions
641Shares Held
95.3MCall Options Held
661KPut Options Held
227K-
Black Rock Inc. New York, NY14.2MShares$1.7 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.21 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$552 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$296 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$283 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...